UNSPSC 51282801: Tinidazole

This classification denotes an antiprotozoal agent with the molecular formula C8H13N3O4S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 033KF7V46H, chemically known as 1h-imidazole, 1-(2-(ethylsulfonyl)ethyl)-2-methyl-5-nitro- but generally known as tinidazole, which bears US NIH Compound Identifier 5479. European Medicines Agency schedules Tinidazole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11074MIG.

UNSPSC 51282801 Tinidazole, a Commodity code, nominally identifies a single antiprotozoal pharmaceutical product, but recent state and local solicitations tagged with this code show minimal direct procurement of tinidazole itself. Instead, the opportunities reveal state and local governments buying broad-spectrum pharmaceutical and medical supply categories — generic multi-source pharmaceuticals, over-the-counter products, emergency medical supplies, and naloxone — through cooperative purchasing agreements, competitive sealed bids, and requests for information aimed at direct-to-manufacturer prescription models. State and local issuing bodies soliciting under this code span cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance, or MMCAP), county health departments (Seminole County, Florida), municipal fire departments (City of Tampa), and state health and human services commissions (Texas Health and Human Services Commission). Procurement vehicles range from traditional IFBs with firm fixed pricing and delivery timelines to exploratory RFIs gathering vendor capabilities before formal solicitation.

Geographic activity is concentrated in Florida, Minnesota (serving multiple states through cooperative purchasing), and Texas, with MMCAP's multi-state purchasing extending to Oregon. Representative recent opportunities include Seminole County's July 2026 IFB seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to a county health facility; the City of Tampa's March 2026 IFB for 169 line items of medical and first aid supplies totaling an estimated $700,000 for the Tampa Fire Department Rescue Division, with a certified Small Local Business Enterprise set-aside and 5% bid discount; and the Minnesota Department of Administration's January 2026 RFP establishing multi-award contracts for generic pharmaceuticals and OTC products through authorized wholesalers with an effective date of July 1, 2026. A Texas Health and Human Services Commission RFI posted in April 2026 sought vendor input on direct-to-manufacturer prescription programs. The mismatch between the code's nominal scope (tinidazole, a specific pharmaceutical) and the actual procurement activity (broad pharmaceutical categories and emergency medical supplies) suggests limited targeted demand for tinidazole itself under this code designation in recent state and local opportunities.